BASF has announced the merger of its Swiss group companies BASF Orgamol Pharma Solutions, Evionnaz, and BASF Fine Chemicals Switzerland, Evionnaz, to a single organization. The company arising from the merger is called BASF Pharma (Evionnaz) and is based in Evionnaz, Switzerland.

President of the new organization is Martin Widmann, general manager of the former BASF Fine Chemicals Switzerland and head of the BASF Pharma Ingredients & Services Business Unit.

"The merger reduces complexity at our site and simplifies processes," Widmann said. "The two companies have been working closely together with success for many years."

Managing Director of BASF Pharma (Evionnaz)will be Dr. Folker Ruchatz, former head of BASF Orgamol Pharma Solutions.

BASF Orgamol Pharma Solutions SA in Evionnaz, Switzerland and its sister company, BASF Orgamol Pharma Solutions France SAS in Saint-Vulbas, France, were uniformly renamed "BASF Pharma" at the end of April 2010.

The merger has no effect on existing contracts with employees, suppliers and customers, which will be transferred unchanged to BASF Pharma (Evionnaz. Nor will there be any change in the number of employees.

The Evionnaz site has a more than 50-year history of producing customized active substances and advanced intermediates exclusively and in complete confidence for pharmaceutical companies. The BASF experts provide services covering the entire pharmaceutical lifecycle, from kilogram-scale production to commercial manufacture and from early-stage clinical development to original product launch and subsequent generic drug status.